Literature DB >> 22696653

Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011.

Martha I Nelson1, Amy L Vincent, Pravina Kitikoon, Edward C Holmes, Marie R Gramer.   

Abstract

Novel H3N2 influenza viruses (H3N2v) containing seven genome segments from swine lineage triple-reassortant H3N2 viruses and a 2009 pandemic H1N1 (H1N1pdm09) matrix protein segment (pM) were isolated from 12 humans in the United States between August and December 2011. To understand the evolution of these novel H3N2 viruses in swine and humans, we undertook a phylogenetic analysis of 674 M sequences and 388 HA and NA sequences from influenza viruses isolated from North American swine during 2009-2011, as well as HA, NA, and M sequences from eight H3N2v viruses isolated from humans. We identified 34 swine influenza viruses (termed rH3N2p) with the same combination of H3, N2, and pM segments as the H3N2v viruses isolated from humans. Notably, these rH3N2p viruses were generated in swine via reassortment events between H3N2 viruses and the pM segment approximately 4 to 10 times since 2009. The pM segment has also reassorted with multiple distinct lineages of H1 virus, especially H1δ viruses. Importantly, the N2 segment of all H3N2v viruses isolated from humans is derived from a genetically distinct N2 lineage that has circulated in swine since being acquired by reassortment with seasonal human H3N2 viruses in 2001-2002, rather than from the N2 that is associated with the 1998 H3N2 swine lineage. The identification of this N2 variant may have implications for influenza vaccine design and the potential pandemic threat of H3N2v to human age groups with differing levels of prior exposure and immunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696653      PMCID: PMC3421719          DOI: 10.1128/JVI.00259-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010.

Authors:  Bo Shu; Rebecca Garten; Shannon Emery; Amanda Balish; Lynn Cooper; Wendy Sessions; Varough Deyde; Catherine Smith; LaShondra Berman; Alexander Klimov; Stephen Lindstrom; Xiyan Xu
Journal:  Virology       Date:  2011-11-10       Impact factor: 3.616

2.  The first identified case of pandemic H1N1 influenza in pigs in Australia.

Authors:  P K Holyoake; P D Kirkland; R J Davis; K E Arzey; J Watson; R A Lunt; J Wang; F Wong; B J Moloney; S E Dunn
Journal:  Aust Vet J       Date:  2011-11       Impact factor: 1.281

3.  The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model.

Authors:  Yi-ying Chou; Randy A Albrecht; Natalie Pica; Anice C Lowen; Jürgen A Richt; Adolfo García-Sastre; Peter Palese; Rong Hai
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-01-06       Impact factor: 17.586

5.  Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus.

Authors:  Seema S Lakdawala; Elaine W Lamirande; Amorsolo L Suguitan; Weijia Wang; Celia P Santos; Leatrice Vogel; Yumiko Matsuoka; William G Lindsley; Hong Jin; Kanta Subbarao
Journal:  PLoS Pathog       Date:  2011-12-29       Impact factor: 6.823

6.  Pandemic A/H1N1/2009 influenza virus in swine, Cameroon, 2010.

Authors:  Kevin Y Njabo; Trevon L Fuller; Anthony Chasar; John P Pollinger; Giovanni Cattoli; Calogero Terregino; Isabella Monne; Jean-Marc Reynes; Richard Njouom; Thomas B Smith
Journal:  Vet Microbiol       Date:  2011-09-12       Impact factor: 3.293

7.  Limited human-to-human transmission of novel influenza A (H3N2) virus--Iowa, November 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-02       Impact factor: 17.586

8.  Emergence of novel reassortant H3N2 swine influenza viruses with the 2009 pandemic H1N1 genes in the United States.

Authors:  Qinfang Liu; Jingjiao Ma; Haixia Liu; Wenbao Qi; Joe Anderson; Steven C Henry; Richard A Hesse; Jürgen A Richt; Wenjun Ma
Journal:  Arch Virol       Date:  2011-12-24       Impact factor: 2.574

9.  Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011.

Authors:  Pravina Kitikoon; Amy L Vincent; Phillip C Gauger; Sarah N Schlink; Darrell O Bayles; Marie R Gramer; Daniel Darnell; Richard J Webby; Kelly M Lager; Sabrina L Swenson; Alexander Klimov
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

10.  Emergence and dissemination of a swine H3N2 reassortant influenza virus with 2009 pandemic H1N1 genes in pigs in China.

Authors:  Xiaohui Fan; Huachen Zhu; Boping Zhou; David K Smith; Xinchun Chen; Tommy T-Y Lam; Leo L M Poon; Malik Peiris; Yi Guan
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

View more
  60 in total

1.  Seasonal H3N2 and 2009 Pandemic H1N1 Influenza A Viruses Reassort Efficiently but Produce Attenuated Progeny.

Authors:  Kara L Phipps; Nicolle Marshall; Hui Tao; Shamika Danzy; Nina Onuoha; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  Pandemic Seasonal H1N1 Reassortants Recovered from Patient Material Display a Phenotype Similar to That of the Seasonal Parent.

Authors:  Stephanie Sonnberg; Mariette F Ducatez; Jennifer DeBeauchamp; Jeri-Carol Crumpton; Adam Rubrum; Bridgett Sharp; Richard J Hall; Matthew Peacey; Sue Huang; Richard J Webby
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

3.  Influenza A Virus Coinfection through Transmission Can Support High Levels of Reassortment.

Authors:  Hui Tao; Lian Li; Maria C White; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

Review 4.  Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface.

Authors:  Martha I Nelson; Amy L Vincent
Journal:  Trends Microbiol       Date:  2015-01-04       Impact factor: 17.079

Review 5.  Transmission of influenza A viruses.

Authors:  Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Virology       Date:  2015-03-24       Impact factor: 3.616

6.  Dynamics of virus shedding and antibody responses in influenza A virus-infected feral swine.

Authors:  Hailiang Sun; Fred L Cunningham; Jillian Harris; Yifei Xu; Li-Ping Long; Katie Hanson-Dorr; John A Baroch; Paul Fioranelli; Mark W Lutman; Tao Li; Kerri Pedersen; Brandon S Schmit; Jim Cooley; Xiaoxu Lin; Richard G Jarman; Thomas J DeLiberto; Xiu-Feng Wan
Journal:  J Gen Virol       Date:  2015-06-25       Impact factor: 3.891

Review 7.  Zoonotic Influenza and Human Health-Part 1: Virology and Epidemiology of Zoonotic Influenzas.

Authors:  L W Goneau; K Mehta; J Wong; A G L'Huillier; J B Gubbay
Journal:  Curr Infect Dis Rep       Date:  2018-08-01       Impact factor: 3.725

8.  The genomic evolution of H1 influenza A viruses from swine detected in the United States between 2009 and 2016.

Authors:  Shibo Gao; Tavis K Anderson; Rasna R Walia; Karin S Dorman; Alicia Janas-Martindale; Amy L Vincent
Journal:  J Gen Virol       Date:  2017-07-31       Impact factor: 3.891

9.  Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression.

Authors:  Daniel Dlugolenski; Les Jones; Elizabeth Howerth; David Wentworth; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

10.  Introductions and evolution of human-origin seasonal influenza a viruses in multinational swine populations.

Authors:  Martha I Nelson; David E Wentworth; Marie R Culhane; Amy L Vincent; Cecile Viboud; Matthew P LaPointe; Xudong Lin; Edward C Holmes; Susan E Detmer
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.